Individualizing therapy for non-small-cell lung cancer: a paradigm shift from empiric to integrated decision-making

Clin Lung Cancer. 2009 May;10(3):148-50. doi: 10.3816/CLC.2009.n.020.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / genetics
  • Decision Making
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / genetics
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Mutation
  • Protein Kinase Inhibitors / therapeutic use
  • Thymidylate Synthase / genetics

Substances

  • Protein Kinase Inhibitors
  • Thymidylate Synthase
  • ErbB Receptors